Navigation Links
Optimizing the Use of Health Outcomes Data in the Marketplace
Date:9/21/2011

CHAPEL HILL, N.C., Sept. 21, 2011 /PRNewswire/ -- Pharmaceutical and biotechnology organizations use health outcomes data to support a variety of product-related initiatives, from treatment guidelines to formulary decisions. With health outcomes data playing such a pivotal role in a product's performance, it's important for organizations to optimize the use of Health Outcomes data.

To help organizations understand current approaches to effectively using health outcomes data in the marketplace, Best Practices, LLC has published a study that examines the internal and external uses of Health Outcomes data for promotional and strategic purposes.

The study, Best Practices in Utilizing Health Outcomes Data, provides comparative data from 2009 and 2011 that illustrate shifting attitudes for how organizations utilize health outcomes data.

Organizations in 2011 used health outcomes data internally mostly for determining market access and scientific publication strategies. Relative to 2009, the importance of using health outcomes data internally for reimbursement decisions increased 24 percent, from 45 percent in 2009 to 69 percent in 2011, according to the study. Meanwhile, in 2011 and 2009, reimbursement and drug formulary decisions were the main use of health outcomes data for interactions with managed care, according to the study.

The 51-page study reflects current approaches to health outcomes data utilization at 16 biopharma organizations; the 2009 data is based on a benchmark class of 29 companies.

The insights in this new study will help pharmaceutical and biotech organizations compare their use of health outcomes data in promotional and internal settings with that of leading organizations. The study also examines the pressing regulatory issues raised by the different uses of health outcomes data.

Key topics covered in this research include:

    '/>"/>

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Prometheus and the Medco Research Institute® to Evaluate the Use of Prometheus Thiopurine Metabolite Testing for Optimizing Treatment of Inflammatory Bowel Disease Patients
2. Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
3. Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas
4. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
5. Health Strategies Group Introduces New One-Stop Suite of Intelligence Services for Optimizing Marketing and Sales Resources in the Institutional Channel
6. Innovative Partnership Helps Improve Medical Research by Optimizing Clinical Trials
7. RadMD Offers Tips on Optimizing Clinical Trial Efficiency
8. At Home Healthcare Expands Telehealth Program With Cardiocom® Telehealth Technology
9. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
10. Genomic Health to Present at the JMP Securities Healthcare Conference
11. Uroplasty to Present at the 6th Annual JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)...  The American Diabetes Association is recommending a ... with diabetes and that all people with diabetes ... in keeping with recent changes to guidelines for ... of Cardiology (ACC) and American Heart Association (AHA). ... changes to the Association,s annual revised Standards of ...
(Date:12/22/2014)... JUNCTION, N.J. , Dec. 22, 2014 /PRNewswire/ ... company marketing its CytoSorb® blood purification technology to ... surgery patients in 28 countries worldwide, today announced ... Russo , MD, FACS, as its Senior Vice ... Dr. Di Russo ...
(Date:12/22/2014)... Research and Markets ( http://www.researchandmarkets.com/research/hmlfbq/investment ... "Investment Analysis of the US Medical Device Sector ... http://photos.prnewswire.com/prnh/20130307/600769 This ... sector identifies the key trends and rationale for ... mergers and acquisitions. The study will ...
Breaking Medicine Technology:New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5Investment Analysis of the US Medical Device Sector 2
... , OMAHA, Neb., Dec. 4 Amber ... Accreditation Commission for Health Care, Inc. (ACHC) for specialized ... provided comprehensive pharmacy care programs and services to meet ... one of the leading providers of services to transplant ...
... , ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE ... against biological and chemical threats, announced today the presentation of ... its lyophilized recombinant Protective Antigen (rPA) based anthrax vaccine is ... up to and including 55 degrees C. The data ...
Cached Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 The ... to 2023” focuses on the current treatment landscape, unmet ... cancer market. TS-1 is an anti-cancer drug which is ... orally and is also used for treating gastric cancer ... and otastat potassium. The drug was first approved in ...
(Date:12/25/2014)... The short film “Color of Honor” by ... of a true 9/11 hero, Welles Remy Crowther. It has ... 24 hours of Nuremberg International Short Film Festival and the ... Actress, screenwriter and director Luciana Lagana plays the mother ... her husband, Gregory Graham - Graham plays a ...
(Date:12/25/2014)... December 25, 2014 Recently, LunaDress.co.uk has updated its ... and related accessories. Now, all of the models at LunaDress.co.uk come ... a groom lifts the wedding veil can turn out to be ... charm. A wedding veil can always bring surprise to a wedding. ... on how to choose veils for a big day . ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... be closing in on a "fountain of youth" drug that ... of older adults, a new study suggests. Seniors received ... drug that targets a genetic signaling pathway linked to aging ... The experimental medication, a version of the ...
(Date:12/25/2014)... Newton, North Carolina (PRWEB) December 25, 2014 ... a North Carolina Retirement Community, recently showed their ... and girls of the Catawba County Parenting Network- ... meal, the 10 children gathered around the largest ... community to open presents purchased by residents of ...
Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Retirement Community Residents Make Impact During Holiday Season 2
... and Eliza Hall,Institute of Medical Research (WEHI) announced ... a leading biotechnology company,based in South San Francisco ... to discover new anti-cancer drugs., "This exciting ... field may increase the chance of translating basic ...
... growing away-from-home ... washroom ... announced it has signed a definitive agreement to acquire,Technical Concepts ... hygiene systems for several high-growth,segments of the away-from-home ("AFH") washroom ...
... High-Performance ... Academia, SOUTHPOINTE, Pa., Feb. 27 ANSYS, ... simulation software and technologies,designed to optimize product development ... and Technology Information (KISTI), one of,the world,s largest ...
... To Enhance Body, Mind & Spirit, VAIL, ... approach to healthcare, Next Step(R) Institute of Integrative,Medicine, ... Colorado, has recently announced its 2008 series of ... Next Step(R) Institute Wellness Weeks are six-night, five-day ...
... popular among,30-somethings who don,t want to look a ... somethings who,d like to look 40 again, StriVectin(R)-HS,Hydro-Thermal ... as the only,"great" beauty serum for older complexions ... just published "beauty serum" ranking., (Photo: ...
... Two emergency care training,organizations acquired by a single ... created parent company at the helm -- and aggressive ... The Riverside Company, which purchased the American Safety & ... over a year,ago, recently created parent company, the Health ...
Cached Medicine News:Health News:Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs 2Health News:Newell Rubbermaid to Grow Commercial Products Platform with Agreement to Acquire Technical Concepts 2Health News:Newell Rubbermaid to Grow Commercial Products Platform with Agreement to Acquire Technical Concepts 3Health News:Newell Rubbermaid to Grow Commercial Products Platform with Agreement to Acquire Technical Concepts 4Health News:KISTI Selects ANSYS as a Key Supplier in Engineering Simulation 2Health News:KISTI Selects ANSYS as a Key Supplier in Engineering Simulation 3Health News:KISTI Selects ANSYS as a Key Supplier in Engineering Simulation 4Health News:Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks 2Health News:Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks 3Health News:Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks 4Health News:America's StriVectin the Only 'Great' Serum for Mature, Aging Complexions, Says Leading British Newspaper 2Health News:New Health & Safety Institute Creates Extensive, Centralized Resource for Emergency Care Training 2
Guaranteed leak-proof , Teflon coating is impervious to corrosive materials , Shock-resistant , NBS tolerances of accuracy , Thermometers are 225 mm long with an immersion length of 35 mm ...
... laboratory system for pH and temperature measurements. ... when used with a temperature probe (ATC) ... easy one and two-point calibration with Auto-Find ... 1.68, 4.00, 7.00, 10.01 and 12.45) and ...
... The DTX Series Multimode Detectors provide ... variety of application and automation needs. ... absorbance measurements on the same instrument, ... standalone instruments or can be integrated ...
... Expert: Detection of PCR, cDNA and Oligonucleotides ... microplate reader for a variety applications that are ... is suitable to handle assays in Microplate ... PCR tubes Cuvettes Independent whether ...
Medicine Products: